Delivery Order SPE2DE24D0013-SPE2D625F2GHQ
- Not listed
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- The U.S. Defense Medical Supply Chain awarded a $1,854 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $1,190.28 to Cepheid Inc. on August 14, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order does not utilize any set-aside designation and represents a discrete procurement under a broader federal vehicle. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in providing advanced diagnostic systems and test kits for...
- The Defense Department's Medical Supply Chain awarded a $16.2K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 27, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of the Department's procurement of diagnostic testing capabilities through Cepheid's established federal contracting vehicles. Cepheid specializes in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,040 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, under contract XPRS4PLEX-10. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, represents a continuation of Cepheid's ongoing provision of diagnostic solutions to federal healthcare systems. The contract carries no set-aside designation,...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2GHQDelivery Order
The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $9,319 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 1, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The delivery order is issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, which provides the company with a framework for supplying molecular diagnostic testing systems, reagents, and assays to federal healthcare systems. Cepheid specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing, with a strong track record of federal contract performance across the VA, Defense Logistics Agency, and Defense Health Agency. The company's GeneXpert diagnostic platform and associated molecular reagents address critical healthcare needs, including detection of COVID-19, influenza, RSV, MRSA, and other infectious pathogens. This delivery order represents a continuation of Cepheid's ongoing support to the federal medical supply chain, building on the company's two significant IDV contracts with the VA valued at approximately $35.3 million combined through fiscal year 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 9/1/25 |